Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis (NASDAQ:OCS) announced the vesting and settlement of Restricted Stock Units (RSUs) for director Arshad Khanani.

Rhea-AI Summary

Oculis (NASDAQ:OCS) announced the vesting and settlement of Restricted Stock Units (RSUs) for director Arshad Khanani. The RSUs were previously granted as part of the company's equity compensation program.

Argus Sep 4 session

+4.89% close to close Open Argus

Details

News Market Reaction – OCS

In the Sep 4 session, OCS gained 4.89%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ZUG, Switzerland, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company.

Attachment

• Notification of managers' transaction - Arshad Khanani - September 2025 RSU vest

FAQ

What type of transaction was announced by Oculis (OCS) on September 3, 2025?

Oculis announced the vesting and settlement of previously granted Restricted Stock Units (RSUs) for director Arshad Khanani.

Who is Arshad Khanani at Oculis (OCS)?

Arshad Khanani is a director at Oculis who received RSUs as part of the company's equity compensation program.

What are RSUs in the context of Oculis stock?

RSUs (Restricted Stock Units) are a form of equity compensation that gives employees and directors the right to receive company stock after meeting vesting requirements.

When did the RSU transaction for Oculis director take place?

The RSU vesting and settlement was announced on September 3, 2025.